Furthermore, Kaplan-Meier analysis of NID2 mRNA expression and patient survival in the International Cancer Genome Consortium (ICGC) PDAC cohort (n = 267) reveals that high NID2 expression is associated with poorer overall survival in patients with pancreatic cancer (Fig. 2A). The gene discussed is NID2; the disease is familial pancreatic carcinoma.